B-cell lymphoma, unclassifiable
GPTKB entity
Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:can_lead_to |
Secondary malignancies
|
| gptkbp:diagnosis |
Biopsy
Variable prognosis Imaging tests Cytogenetic analysis Flow cytometry |
| https://www.w3.org/2000/01/rdf-schema#label |
B-cell lymphoma, unclassifiable
|
| gptkbp:is_a |
gptkb:Oncology
|
| gptkbp:is_associated_with |
Environmental factors
Autoimmune diseases Immunodeficiency Viral infections Chronic inflammation |
| gptkbp:is_characterized_by |
Genetic mutations
B-cell proliferation Cytological atypia Heterogeneous presentation Infiltration of lymphoid tissue Presence of Reed-Sternberg-like cells |
| gptkbp:is_common_in |
Adults
Elderly Males People over 60 |
| gptkbp:is_linked_to |
Radiation exposure
Exposure to chemicals Genetic predisposition Immune system disorders Chronic infections Family history of lymphoma Previous cancer treatment |
| gptkbp:is_part_of |
gptkb:Oncology
Hematologic malignancies Lymphoproliferative disorders |
| gptkbp:is_recognized_by |
Molecular diagnostics
Immunohistochemistry Histopathological examination |
| gptkbp:is_related_to |
gptkb:Oncology
gptkb:Non-Hodgkin_lymphoma |
| gptkbp:is_studied_for |
Treatment outcomes
Survival rates Genetic profiling |
| gptkbp:is_studied_in |
Clinical trials
|
| gptkbp:scientific_classification |
Aggressive lymphoma
Intermediate-grade lymphoma |
| gptkbp:symptoms |
gptkb:Fever
Night sweats Swollen lymph nodes Weight loss |
| gptkbp:treatment |
gptkb:immunotherapy
Chemotherapy Radiation therapy Monoclonal antibodies Stem cell transplant Targeted therapy Combination chemotherapy |
| gptkbp:bfsParent |
gptkb:large_B-cell_lymphoma
|
| gptkbp:bfsLayer |
6
|